BridgeMD
New treatment option for Eating Disorders (Excluding Anorexia Nervosa)
Official title CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa
ClinicalTrials.gov ID: NCT07037017
What this study is testing
- What it's testing
- This randomized controlled trial investigates the neurophysiological, physiological, and attentional effects of Cognitive-Behavioral Therapy (CBT) in individuals with restrictive-type anorexia nervosa (AN). The study compares two groups: one receiving a 12-week CBT intervention, and one placed on a waitlist (no active treatment during the study period).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only
You may be able to join if
- Female participants aged 18 to 35
- Meeting DSM-5 diagnostic criteria for restrictive-type anorexia nervosa
- Body Mass Index (BMI) between 15.0 and 18.5
- Medically stable to participate in psychological and neurophysiological assessments
- Willingness to participate in weekly therapy sessions (for the CBT group) and to complete pre- and post-assessments
You likely can't join if
- Current or past diagnosis of bulimia nervosa, binge-eating disorder, or other eating disorders
- Presence of comorbid severe psychiatric disorders (e.g., psychosis, bipolar disorder, substance use disorder)
- History of neurological illness or traumatic brain injury
- Use of psychotropic medication within the last 6 weeks
- Prior participation in structured Cognitive-Behavioral Therapy for an eating disorder
- Pregnancy
See the full eligibility criteria
- Female participants aged 18 to 35
- Meeting DSM-5 diagnostic criteria for restrictive-type anorexia nervosa
- Body Mass Index (BMI) between 15.0 and 18.5
- Medically stable to participate in psychological and neurophysiological assessments
- Willingness to participate in weekly therapy sessions (for the CBT group) and to complete pre- and post-assessments
- Ability to provide informed consent
- Current or past diagnosis of bulimia nervosa, binge-eating disorder, or other eating disorders
- Presence of comorbid severe psychiatric disorders (e.g., psychosis, bipolar disorder, substance use disorder)
- History of neurological illness or traumatic brain injury
- Use of psychotropic medication within the last 6 weeks
- Prior participation in structured Cognitive-Behavioral Therapy for an eating disorder
- Pregnancy
- Visual or neurological impairments that would prevent accurate EEG, GSR, or eye-tracking recordings
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.